Condition

Primary CNS Lymphoma (PCNSL) clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Primary CNS Lymphoma (PCNSL) clinical trials that are recruiting, at sites in 2 countries (most in South Korea (2), France (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Primary CNS Lymphoma (PCNSL) clinical trials

StudyPhaseWhereStatusRegistered
Anbalcabtagene autoleucel for relapsed or refractory CNS B‑cell lymphoma Phase 2 Seoul Recruiting Jul 14, 2025
Epcoritamab with lenalidomide and rituximab for relapsed or refractory primary diffuse large B‑cell lymphoma of the CNS Phase 2 Bordeaux and 12 other locations Recruiting Apr 17, 2025
Combination therapy for relapsed or refractory primary CNS lymphoma Phase 2 Busan and 9 other locations Recruiting Dec 17, 2024

All recruiting trials (3)

Related topics

RituximabDiffuse Large B Cell Lymphoma (DLBCL)Epcoritamab

Quick answers

How many Primary CNS Lymphoma (PCNSL) clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in South Korea (2 trials), France (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.